All news

After a $20.4M sale, Regeneron (REGN) director George L. Sing proposes selling 1,000 more shares.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Regeneron Pharmaceuticals, Inc. director George L. Sing has proposed selling an additional 1,000 common shares, valued at approximately $957,687.10, with an approximate sale date of November 17, 2026. This proposed sale follows two recent insider transactions where Sing sold 1,000 shares for $960,264.40 on November 16, 2026, and 21,129 shares for $20,376,359.76 on November 2, 2026.

Read original source

REGN company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.